| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 65.46% | -6.7% | -1.29% | 37/140 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 66.32% | -4.61% | -5.43% | 34/140 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 70.13% | 0.36% | -0.37% | 23/140 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 70.39% | -0.04% | 0.31% | 23/140 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 70.17% | -0.49% | 0.93% | 23/140 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 69.52% | 0.44% | -0.51% | 26/140 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 69.88% | -0.89% | -0.77% | 28/140 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 70.42% | -1.72% | -0.14% | 26/140 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 70.51% | -0.74% | 1.88% | 27/140 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 69.21% | -3.19% | -1.83% | 32/140 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 70.5% | 2.21% | -1.6% | 26/140 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 71.65% | 2.27% | 0.86% | 20/140 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 71.04% | 1.72% | -0.64% | 26/140 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 71.49% | 6.68% | 3.64% | 21/140 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 68.98% | -4.33% | -1.54% | 31/140 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 70.06% | -5.64% | 0.32% | 28/140 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 69.84% | -6.3% | 4.21% | 30/140 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 67.02% | -10.38% | -7.06% | 39/140 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 72.1% | -3.77% | -2.88% | 31/140 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 74.24% | -3.28% | -0.39% | 26/140 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 74.53% | -3.46% | -0.32% | 26/140 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 74.77% | -1.22% | -0.21% | 24/140 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 74.93% | -3.08% | -2.38% | 30/140 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 76.76% | -0.82% | -0.58% | 22/140 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 77.21% | 0.76% | 1.99% | 26/140 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 75.7% | 2% | -2.08% | 17/140 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 77.31% | -1.57% | -0.11% | 23/140 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 77.4% | 2% | 1.01% | 12/140 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 76.62% | -8.77% | -2.45% | 18/140 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 78.54% | -0.18% | -0.18% | 20/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2017-12-31 | 78.68% | -5.84% | -5.84% | 15/140 | 56.1% | 正海生物 | 93.08% | 行业排名> |
| 2016-12-31 | 83.56% | 2.03% | -0.51% | 7/140 | 57.35% | 正海生物 | 92.83% | 行业排名> |

微信公众号
证券之星APP


